IL1B and atherosclerosis: While in atherosclerosis it could be beneficial to inhibit immune cell infiltrations as evident that treatment with anti-IL-1B can provide additional cardio-protective benefits by reducing leukocyte recruitment to the atherosclerotic plaque as well as reducing its size (53).